臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"kao j h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 596-645 of 1534 (31 Page(s) Totally)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-07-03T03:33:31Z	Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis	Liu C.-H.;Shih Y.-L.;Yang S.-S.;Lin C.-L.;Fang Y.-J.;Cheng P.-N.;Chen C.-Y.;Peng C.-Y.;Hsieh T.-Y.;Chiu Y.-C.;Su T.-H.;Liu C.-J.;Yang H.-C.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:29Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.;Liu C.-J.;Hsu C.-Y.;Hong C.-M.;Su T.-H.;Yang W.-T.;Chen C.-L.;Yang H.-C.;Huang Y.-T.;Fang-Tzu Kuo S.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:28Z	Gender difference in the association between metabolic factors and hepatocellular carcinoma	Chen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; Yang W.-S.; Kao J.-H.; PEI-JER CHEN; Chen H.-H.
臺大學術典藏	2021-07-03T03:33:28Z	Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis	Su T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:27Z	Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy	Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:27Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan	Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:26Z	HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis	Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:26Z	Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment	Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:26Z	Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals	Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:25Z	2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population	Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.
臺大學術典藏	2021-07-03T03:33:24Z	Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing	Yang Y.-C.; Chen Y.-H.; Kao J.-H.; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Yang H.-C.
臺大學術典藏	2021-07-03T03:33:23Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-07-03T03:33:23Z	2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations	Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.
臺大學術典藏	2021-07-03T03:33:23Z	Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer	Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:22Z	Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan	Su H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; Su T.-H.; PEI-JER CHEN; Liu C.-J.
臺大學術典藏	2021-07-03T03:33:21Z	High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy	Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:20Z	Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan	Liu C.-H.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:20Z	Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis	Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:17Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; PEI-JER CHEN; Kao J.-H.
臺大學術典藏	2021-07-02T03:43:04Z	Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C	Yang P.-M.; Hwang L.-H.; Lai M.-Y.; Huang W.-L.; Chu Y.-D.; Chi W.-K.; BOR-LUEN CHIANG; Kao J.-H.; Chen P.-J.; Chen D.-S.
臺大學術典藏	2021-07-02T03:43:02Z	Identification of humoral antigenic determinants in the hepatitis C virus NS3 protein	Hwang L.-H.; Yang P.-M.; Lai M.-Y.; BOR-LUEN CHIANG; Kao J.-H.; Wang J.-T.; Lee S.-Y.; Chian H.-M.; Chi W.-K.; Chu Y.-D.; Chen P.-J.; Chen D.-S.
臺大學術典藏	2021-07-02T03:41:50Z	Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy	Liang C.-C.; Liu C.-H.; Lin Y.-L.; Liu C.-J.; BOR-LUEN CHIANG; Kao J.-H.
臺大學術典藏	2021-07-02T03:41:07Z	Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics	Liu W.-D.; Chang S.-Y.; Lan T.-Y.; Lin Y.-C.; Kao J.-H.; Liao C.-H.; Tsai M.-J.; Kuo P.-H.; Huang Y.-S.; Wang J.-T.; Sheng W.-H.; Hsieh S.-C.; BOR-LUEN CHIANG; Chen Y.-C.; Chang S.-C.
臺大學術典藏	2021-07-02T02:35:59Z	Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C	Liu C.-J.; Chen P.-J.; Jeng Y.-M.; Huang W.-L.; WEI-SHIUNG YANG; Lai M.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-02T02:35:59Z	Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-α therapy	Lu J.-Y.; Chuang L.-M.; WEI-SHIUNG YANG; Tai T.-Y.; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Lee C.-Z.; Lee H.-S.
臺大學術典藏	2021-07-02T02:35:50Z	Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients	Chu C.-H.; Yang A.-M.; Kao J.-H.; Liu C.-Y.; Chang W.-H.; WEI-SHIUNG YANG
臺大學術典藏	2021-07-02T02:35:35Z	Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan	Chen C.-L.; WEI-SHIUNG YANG; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; Kao J.-H.; Chen P.-J.; Chen D.-S.; Chen C.-J.
臺大學術典藏	2021-07-02T02:35:20Z	High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments	Nien H.-C.; Hsu S.-J.; Su T.-H.; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; Kao J.-H.; WEI-SHIUNG YANG
臺大學術典藏	2021-07-02T02:35:15Z	One-year weight management lowers lipopolysaccharide-binding protein and its implication in metainflammation and liver fibrosis	Nien H.-C.; Sheu J.-C.; Chi Y.-C.; Chen C.-L.; Kao J.-H.; WEI-SHIUNG YANG
臺大學術典藏	2021-07-02T02:35:12Z	Gender difference in the association between metabolic factors and hepatocellular carcinoma	Chen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; WEI-SHIUNG YANG; Kao J.-H.; Chen P.-J.; Chen H.-H.
臺大學術典藏	2021-06-25T08:10:15Z	Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:15Z	Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection	Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:15Z	A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients	Liu C.-H.; Liu C.-J.; CHUN-MING HONG; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏	2021-06-25T08:10:14Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:14Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	Liu C.-H.; Su T.-H.; Liu C.-J.; CHUN-MING HONG; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	Su T.-H.; Liao S.-H.; CHUN-MING HONG; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:12Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	CHUN-MING HONG; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-06-25T08:10:12Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; CHUN-MING HONG; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:11Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; CHUN-MING HONG; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H.
臺大學術典藏	2021-06-24T07:17:14Z	Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy	Sheng W.-H.; Kao J.-H.; Chen P.-J.; LI-MIN HUANG; Chang S.-Y.; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C.
臺大學術典藏	2021-06-15T03:12:29Z	Acute pancreatitis complicated by infarction of the spleen and spinal cord	SHU-CHEN WEI; Kao J.-H.; Lee W.-Y.; Lin J.-T.; Wang T.-H.
臺大學術典藏	2021-06-15T03:12:12Z	Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy	Huang Y.-W.; Lin S.-C.; SHU-CHEN WEI; Hu J.-T.; Chang H.-Y.; Huang S.-H.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; Kao J.-H.
臺大學術典藏	2021-06-15T03:12:11Z	Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy	Huang Y.-W.; Hsu C.-K.; Lin S.-C.; SHU-CHEN WEI; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; Kao J.-H.
臺大學術典藏	2021-06-03T06:50:15Z	Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition	Su T.-H.;Shiau C.-W.;Jao P.;Liu C.-H.;Liu C.-J.;Tai W.-T.;Jeng Y.-M.;Yang H.-C.;Tseng T.-C.;Hsiang-Po Huang;Cheng H.-R.;Chen P.-J.;Chen K.-F.;Kao J.-H.;Chen D.-S.; Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; HSIANG-PO HUANG; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-05-27T09:07:07Z	Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients	Peng Y.-S.;Chih-Kang Chiang;Hsu S.-P.;Pai M.-F.;Hung K.-Y.;Kao J.-H.; Peng Y.-S.; CHIH-KANG CHIANG; Hsu S.-P.; Pai M.-F.; Hung K.-Y.; Kao J.-H.
臺大學術典藏	2021-05-27T09:06:54Z	Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients	Tsai H.-B.;Chen P.-C.;Liu C.-H.;Hung P.-H.;Chen M.-T.;Chih-Kang Chiang ;Kao J.-H.;Hung K.-Y.; Tsai H.-B.; Chen P.-C.; Liu C.-H.; Hung P.-H.; Chen M.-T.; CHIH-KANG CHIANG; Kao J.-H.; Hung K.-Y.
臺大學術典藏	2021-05-27T08:20:46Z	Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy	Su T.-H.; Yang H.-C.; Tseng T.-C.; JYH-MING LIOU; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏	2021-05-26T03:35:07Z	Paratyphoid hepatitis: An emerging clinical entity [5]	Hsueh P.-R.; Kao J.-H.; Chen Y.-C.; Yang P.-C.; KWEN-TAY LUH; Wang T.-K.; Lin S.-F.

Showing items 596-645 of 1534 (31 Page(s) Totally)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2856565
	???header.visitor??? : 53378078 ???header.onlineuser??? : 1291 ???header.sponsordeclaration???